Baldwin Wealth Partners’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-75
Closed -$14K 554
2018
Q3
$14K Buy
+75
New +$13.8K ﹤0.01% 439
2017
Q4
Sell
-1,875
Closed -$384K 515
2017
Q3
$384K Hold
1,875
0.06% 141
2017
Q2
$456K Hold
1,875
0.07% 129
2017
Q1
$448K Hold
1,875
0.07% 133
2016
Q4
$394K Sell
1,875
-1,155
-38% -$239K 0.07% 139
2016
Q3
$698K Buy
3,030
+1,850
+157% +$452K 0.13% 99
2016
Q2
$273K Buy
1,180
+19
+2% +$4.38K 0.06% 148
2016
Q1
$311K Buy
1,161
+386
+50% +$110K 0.06% 176
2015
Q4
$242K Hold
775
0.04% 202
2015
Q3
$211K Hold
775
0.04% 214
2015
Q2
$235K Buy
+775
New +$231K 0.03% 214

Other funds holding AGN

Baldwin Wealth Partners's AGN Position: Q4 2018 in Review

Baldwin Wealth Partners sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 75 shares — an estimated $14K sold.

Baldwin Wealth Partners first reported a position in AGN in Q2 2015 and held it in 11 quarters. The position peaked at $698K in Q3 2016. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Baldwin Wealth Partners reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Baldwin Wealth Partners sold 75 Allergan plc shares in Q4 2018, an estimated $14K.
  • Baldwin Wealth Partners first reported a position in Allergan plc in Q2 2015 and held it in 11 quarters.
  • Baldwin Wealth Partners's Allergan plc position peaked at $698K in Q3 2016.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Baldwin Wealth Partners's 13F filing for Q4 2018, filed 1 Feb 2019.